266 related articles for article (PubMed ID: 22706965)
1. IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.
Park H; Serti E; Eke O; Muchmore B; Prokunina-Olsson L; Capone S; Folgori A; Rehermann B
Hepatology; 2012 Dec; 56(6):2060-70. PubMed ID: 22706965
[TBL] [Abstract][Full Text] [Related]
2. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.
Brownell J; Wagoner J; Lovelace ES; Thirstrup D; Mohar I; Smith W; Giugliano S; Li K; Crispe IN; Rosen HR; Polyak SJ
J Hepatol; 2013 Oct; 59(4):701-8. PubMed ID: 23770038
[TBL] [Abstract][Full Text] [Related]
3. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.
Thomas E; Gonzalez VD; Li Q; Modi AA; Chen W; Noureddin M; Rotman Y; Liang TJ
Gastroenterology; 2012 Apr; 142(4):978-88. PubMed ID: 22248663
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
Wang Y; Ye L; Wang X; Li J; Song L; Ho W
Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
[TBL] [Abstract][Full Text] [Related]
5. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
[TBL] [Abstract][Full Text] [Related]
6. Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.
Brownell J; Bruckner J; Wagoner J; Thomas E; Loo YM; Gale M; Liang TJ; Polyak SJ
J Virol; 2014 Feb; 88(3):1582-90. PubMed ID: 24257594
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.
Todt D; François C; Anggakusuma ; Behrendt P; Engelmann M; Knegendorf L; Vieyres G; Wedemeyer H; Hartmann R; Pietschmann T; Duverlie G; Steinmann E
Antimicrob Agents Chemother; 2016 Apr; 60(4):2132-9. PubMed ID: 26787701
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures.
Marukian S; Andrus L; Sheahan TP; Jones CT; Charles ED; Ploss A; Rice CM; Dustin LB
Hepatology; 2011 Dec; 54(6):1913-23. PubMed ID: 21800339
[TBL] [Abstract][Full Text] [Related]
9. High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.
Cheng M; Si Y; Niu Y; Liu X; Li X; Zhao J; Jin Q; Yang W
J Virol; 2013 Sep; 87(17):9707-18. PubMed ID: 23824794
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex.
Lee HC; Narayanan S; Park SJ; Seong SY; Hahn YS
J Biol Chem; 2014 Feb; 289(8):5310-9. PubMed ID: 24385435
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
MacParland SA; Ma XZ; Chen L; Khattar R; Cherepanov V; Selzner M; Feld JJ; Selzner N; McGilvray ID
J Virol; 2016 Jun; 90(12):5549-5560. PubMed ID: 27009955
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus Evades Interferon Signaling by Suppressing Long Noncoding RNA Linc-Pint Involving C/EBP-β.
Khatun M; Zhang J; Ray R; Ray RB
J Virol; 2021 Aug; 95(17):e0095221. PubMed ID: 34160260
[TBL] [Abstract][Full Text] [Related]
14. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
15. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication.
Giugliano S; Kriss M; Golden-Mason L; Dobrinskikh E; Stone AE; Soto-Gutierrez A; Mitchell A; Khetani SR; Yamane D; Stoddard M; Li H; Shaw GM; Edwards MG; Lemon SM; Gale M; Shah VH; Rosen HR
Gastroenterology; 2015 Feb; 148(2):392-402.e13. PubMed ID: 25447848
[TBL] [Abstract][Full Text] [Related]
17. Multi-step regulation of interferon induction by hepatitis C virus.
Oshiumi H; Funami K; Aly HH; Matsumoto M; Seya T
Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):127-38. PubMed ID: 23292079
[TBL] [Abstract][Full Text] [Related]
18. MxA is a positive regulator of type I IFN signaling in HCV infection.
Shi X; Jiao B; Chen Y; Li S; Chen L
J Med Virol; 2017 Dec; 89(12):2173-2180. PubMed ID: 28561372
[TBL] [Abstract][Full Text] [Related]
19. Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.
Anggakusuma ; Frentzen A; Gürlevik E; Yuan Q; Steinmann E; Ott M; Staeheli P; Schmid-Burgk J; Schmidt T; Hornung V; Kuehnel F; Pietschmann T
J Virol; 2015 Apr; 89(7):3833-45. PubMed ID: 25609814
[TBL] [Abstract][Full Text] [Related]
20. Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression.
Ferraris P; Chandra PK; Panigrahi R; Aboulnasr F; Chava S; Kurt R; Pawlotsky JM; Wilkens L; Osterlund P; Hartmann R; Balart LA; Wu T; Dash S
Am J Pathol; 2016 Apr; 186(4):938-51. PubMed ID: 26896692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
